THE EFFECT OF A NEW PROBIOTIC PRODUCT LINE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: CLINICAL OBSERVATION.

Journal Title: International Journal of Advanced Research (IJAR) - Year 2018, Vol 6, Issue 5

Abstract

Background It has been proven for many years that probiotics play pivotal role in the treatment of IBS patients. However it is still not very clear which strains are more beneficial than others in the treatment of irritable bowel syndrome (IBS).Our aim in the current clinical observation was to follow up the effect of a novel probiotic product line available on the Bulgarian market - Biopron IB-Symbio (Walmark, Czech Republic) in the treatment of IBS patients. Methods This prospective clinical observation included 45 consecutive patients divided into three groups: group 1 – 15 patients with diarrhea predominant post-infectious IBS (IBS-D), group 2 - 15 with constipation-predominant IBS (IBS-C) and group 3 – 15 IBS patients meeting Rome III but not meeting Rome IV criteria. Four week monotherapy with a new probiotic line was commenced in every group. The symptoms were evaluated before and after treatment. Moreover in IBS-D group fecal calprotectin (FCP) was monitored Results Significant reduction of FCP mean levels was observed in group 1 – from 152 µg/g at week 0 to 64 µg/gat week 4 (p<0,001). After probiotic treatment diarrhea was present only in 3 (20%) patients, and pain in 5 (33%) of the patients. In group 2 constipation was present after treatment just in 2 (13%) patients and abdominal pain in 4 (27%) of them. In group 3 - at 4 week after treatment discomfort was present in 3 (20%) patients, bloating in 2 (13%) patients and change in frequency of stool in 4 (27%) Conclusion The current clinical observation shows that Biopron probiotic product line significantly improves the symptoms in IBS patients. Moreover, it reduces the inflammatory activity in patients with post-infectious IBS.Additional multicenter observations with larger number of patients from different regions are needed to obtain even more accurate data

Authors and Affiliations

Ventsislav Nakov, Radislav Nakov.

Keywords

Related Articles

INVESTIGATION ON THE MYCODIVERSITY OF FRESH FRUITS OF PHYLLANTHUS EMBLICA L., AN IMPORTANT MEDICINAL PLANT, FROM JAMMU PROVINCE (INDIA).

An investigation of mycoflora was carried out from market samples of fresh fruit of Phyllanthus emblica L., an important medicinal plant of India. The samples were collected from various wholesale and retail shops as wel...

ANTI-CORROSIVE PROPERTIES OF SILICA NANOPARTICLES AND RARE EARTH SEALING ON ANODIZED ALUMINUM.

The present study is aimed at investigating the electrochemical characteristics of aluminum alloy due to the deposition of SiO2 nanoparticles by electrophoretic deposition (EPD) inside a porous anodic aluminum oxide film...

YIELD AND FORAGE QUALITY OF ELEPHANT GRASS IN RESPONSE TO CUTTING INTERVALS.

The aim of the study was to identify the shorter cutting intervals in relation to the production and quality of forage. Treatments consisted of two forages cutting frequencies: 12 and 8 cutting frequencies per year_1 (4...

AUTOMATIC STAR DELTA STARTER.

This equipment/appliance reduces starting current and starting torque. Automatic Star Delta Starter design normally consists of three contactors, an overload relay or circuit breaker, and a timer for setting the time in...

RADIX VISTA: A CASE SERIES.

With the increasing number of reports of aberrant root canal morphology, the clinician needs to be aware of the variable anatomy.Normally the permanent mandibular first molar has two roots, mesial and distal, but mandibu...

Download PDF file
  • EP ID EP297964
  • DOI 10.21474/IJAR01/7122
  • Views 41
  • Downloads 0

How To Cite

Ventsislav Nakov, Radislav Nakov. (2018). THE EFFECT OF A NEW PROBIOTIC PRODUCT LINE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: CLINICAL OBSERVATION.. International Journal of Advanced Research (IJAR), 6(5), 1001-1006. https://europub.co.uk/articles/-A-297964